Guardant Health, Inc. Financial Ratios — 5GH Stock

Profitability (USD)

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-11.81	-24.21	-41.75	-185.65	-438.13	- -	- -
Return on Assets (%)	- -	-36.22	-18.29	-9.76	-15.69	-18.13	-34.32	-28.23	-26.67	-23.79
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	12.38	36.56	52.33	67.01	67.73	67.11	65.23	59.74	60.79	64.46
EBITDA Margin (%)	-159.03	-143.26	-94.67	-33.1	-83.31	-104.04	-113.1	-92.53	-54.29	-40.48
Operating Margin (%)	-173.66	-153.71	-102.54	-38.42	-88.92	-110	-121.1	-100.14	-60.02	-44.53
Incremental Operating Margin (%)	- -	- -	- -	8.54	- -	- -	- -	- -	69.19	2.61
Pretax Margin (%)	-182.71	-166.96	-92.92	-32.52	-85.76	-102.89	-145.36	-84.9	-58.87	-42.52
Profit Margin (%)	-182.74	-166.97	-93.85	-35.29	-88.51	-108.57	-145.61	-85.02	-59.05	-42.39
Net Income to Common Margin (%)	-182.74	-178.55	-93.85	-35.29	-88.51	-108.57	-145.61	-85.02	-59.05	-42.39
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	6.49	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-11.81	-24.21	-41.75	-185.65	-438.13	- -	- -

Credit (USD)

Credit Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	17	1	- -	40	854	1,374	1,369	1,354	1,336	1,710
ST Debt	- -	- -	- -	7	7	13	22	28	29	28
LT Debt	17	- -	- -	33	848	1,361	1,347	1,326	1,307	1,682
Total Debt/EBITDA	-0.42	-0.01	- -	-0.57	-3.58	-3.53	-2.69	-2.59	-3.33	-4.3
Net Debt/EBITDA	0.43	1.01	1.64	2.02	0.11	-1.65	-1.96	-0.01	-1.54	-2.83
Total Debt/EBIT	-0.39	-0.01	- -	-0.49	-3.35	-3.34	-2.52	-2.4	-3.01	-3.91
Net Debt/EBIT	0.39	0.94	1.51	1.74	0.1	-1.56	-1.83	-0.01	-1.39	-2.57
EBITDA to Interest Expense	-13.3	-26.43	-68.59	-60.08	-50.12	-150.85	-197.29	-202.42	-155.45	-102
EBITDA-CapEx/Interest Expense	-13.89	-29.75	-84.74	-78.11	-61.47	-179.96	-227.35	-210.37	-169.04	-114.4
EBIT to Interest Expense	-14.53	-28.35	-74.29	-69.75	-53.49	-159.49	-211.24	-219.06	-171.87	-112.2
Interest Expense	3	3	1	1	5	3	3	3	3	4
Common Equity/Total Assets	-86.05	-55.8	82.25	82.95	57.16	29.26	3.74	8.88	-9.4	-4.93
Long-Term Debt/Equity (%)	21.22	0.15	- -	3.92	62.55	210.99	2,238.96	835.51	- -	- -
Long-Term Debt/Capital (%)	17.48	0.15	- -	3.74	38.36	67.41	94.26	87.66	109.23	104.45
Long-Term Debt/Total Assets (%)	14.51	0.13	- -	3.46	37.32	61.73	83.69	74.22	87.97	83.55
Total Debt/Equity (%)	21.38	0.21	0.02	4.76	63.03	212.98	2,275.31	853.12	-956.74	-1,722.08
Total Debt/Capital (%)	17.61	0.21	0.02	4.55	38.66	68.05	95.79	89.51	111.67	106.16
Total Debt/Total Assets (%)	14.62	0.19	0.02	4.2	37.61	62.31	85.05	75.78	89.93	84.93
Net Debt to Equity	-21.47	-23.42	-26.77	-16.89	-1.97	99.63	1,654.61	4.05	-441.83	-1,133.65
Net Debt/Capital (%)	-27.1	-30.5	-36.55	-19.22	-1.94	42.1	77.32	1.7	91.97	91.33
EBITDA	-40	-71	-86	-71	-239	-389	-508	-522	-401	-398
EBITDA-CapEx	-42	-80	-106	-92	-293	-464	-586	-542	-436	-446
Operating Income (Loss)	-44	-77	-93	-82	-255	-411	-544	-565	-444	-437

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	6.67	11.28	8.92	7.19	26.87	4.79	5.23	5.68	3.72	3.97
Current Ratio	7.22	12.38	9.99	8.21	28.27	5.72	6.17	6.54	4.68	4.84
Quick Ratio	6.92	11.93	9.68	7.85	27.66	5.29	5.74	6.11	4.21	4.42
CFO/Avg Current Liab	- -	-4.26	-2.17	-0.79	-1.49	-1.6	-1.6	-1.63	-1.11	-0.7
Common Equity/Total Assets	-86.05	-55.8	82.25	82.95	57.16	29.26	3.74	8.88	-9.4	-4.93
Long-Term Debt/Equity (%)	21.22	0.15	- -	3.92	62.55	210.99	2,238.96	835.51	- -	- -
Long-Term Debt/Capital (%)	17.48	0.15	- -	3.74	38.36	67.41	94.26	87.66	109.23	104.45
Long-Term Debt/Total Assets (%)	14.51	0.13	- -	3.46	37.32	61.73	83.69	74.22	87.97	83.55
Total Debt/Equity (%)	21.38	0.21	0.02	4.76	63.03	212.98	2,275.31	853.12	-956.74	-1,722.08
Total Debt/Capital (%)	17.61	0.21	0.02	4.55	38.66	68.05	95.79	89.51	111.67	106.16
Total Debt/Total Assets (%)	14.62	0.19	0.02	4.2	37.61	62.31	85.05	75.78	89.93	84.93
CFO/Total Liabilities	-99.57	-210.4	-115.59	-41.15	-11.34	-13.4	-19.97	-19.96	-14.76	-8.74
CFO/CapEx	-20.79	-8.04	-3.57	-2.21	-1.92	-2.79	-4	-15.86	-6.84	-3.82
Altman's Z-Score	- -	- -	- -	- -	8.22	3.15	-0.49	-0.41	-0.88	2.03

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	6.12	3.74	5.12	5.66	4.95	4.61	6.23	7.75	8.2
Days Sales Outstanding	- -	59.62	97.61	71.23	64.47	73.73	79.13	58.62	47.1	44.51
Inventory Turnover	- -	6.29	5.26	5.82	4.88	4.6	3.8	4	4.36	4.45
Days Inventory Outstanding	- -	58.04	69.36	62.75	74.74	79.27	96.05	91.27	83.78	82.08
Accounts Payable Turnover	- -	8.86	5.76	5.72	8.5	5.71	3.3	3.94	6.62	7.82
Accounts Payable Turnover Days	- -	41.19	63.35	63.81	42.92	63.95	110.61	92.75	55.12	46.65
Cash Conversion Cycle	- -	76.48	103.63	70.18	96.28	89.05	64.56	57.13	75.75	79.94
Inventory to Cash Days	- -	1.57	28.24	8.48	-10.27	-5.55	-16.92	-32.65	-36.67	-37.57
Inventories	3	7	9	15	23	31	52	62	71	86
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	3	7	9	15	23	31	52	62	71	86

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	12,021	9,733	2,753	3,357	3,737	13,151
- Cash & Cash Equivalents	34	72	141	143	833	492	142	1,134	526	378
+ Preferred Equity and Hybrid Capital	180	500	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	42	50	57	- -	- -	- -	- -	- -
+ Total Debt	17	1	- -	40	854	1,374	1,369	1,354	1,336	1,710
Enterprise Value	- -	- -	- -	- -	11,138	10,174	3,111	3,542	4,233	13,660
Total Capital	97	309	525	888	2,210	2,019	1,429	1,512	1,196	1,611
Total Debt/Capital (%)	17.61	0.21	0.02	4.55	38.66	68.05	95.79	89.51	111.67	106.16
Total Debt / EV	- -	- -	- -	- -	0.08	0.14	0.44	0.38	0.32	0.13
EV/Sales	- -	- -	- -	- -	38.84	27.23	6.92	6.28	5.73	13.91
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	11,696	9,690	2,741	3,091	3,699	12,621
Diluted Enterprise Value	- -	- -	- -	- -	10,813	10,130	3,099	3,276	4,195	13,130
EV per Share	- -	- -	- -	- -	111.14	99.97	30.31	29.12	34.14	104.56
TTM Sales	25	50	91	214	287	374	450	564	739	982
TTM EBITDA	-40	-71	-86	-71	-239	-389	-508	-522	-401	-398
TTM Operating Income	-44	-77	-93	-82	-255	-411	-544	-565	-444	-437
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	-74.03	-34.11	-7.08	-8.95	-13.45	-54.15
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	11,138	10,174	3,111	3,542	4,233	13,660
Low Price	- -	- -	- -	- -	110.81	87.68	25.19	20.85	16	30.32
EV/Sales	- -	- -	- -	- -	38.84	27.23	6.92	6.28	5.73	13.91
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	9.26	15.09	45.74	21.15	-26.76	-132.43
Price/Book Value Average	- -	- -	- -	- -	9.47	19.88	91.06	22.72	-22.45	-75.48
Price/Book Value High	- -	- -	- -	- -	10.63	29.72	171.25	30.42	-33.81	-146.39
Price/Book Value Low	- -	- -	- -	- -	8.55	13.83	42.96	15.98	-14.21	-39.89
Price/Tangible Book Value	- -	- -	- -	- -	9.4	15.51	60.95	22.93	-24.96	-64.95
Price/Tangible Book Value Average	- -	- -	- -	- -	9.61	20.43	121.34	24.63	-20.94	-37.02
Price/Tangible Book Value High	- -	- -	- -	- -	10.79	30.55	228.19	32.97	-31.54	-71.8
Price/Tangible Book Value Low	- -	- -	- -	- -	8.68	14.22	57.24	17.32	-13.26	-19.56
Price/Sales	- -	- -	- -	- -	40.79	25.93	6.1	5.48	5.01	12.85
Price/Sales Average	- -	- -	- -	- -	41.71	34.16	12.14	5.89	4.2	7.33
Price/Sales High	- -	- -	- -	- -	46.84	51.08	22.83	7.88	6.32	14.21
Price/Sales Low	- -	- -	- -	- -	37.68	23.77	5.73	4.14	2.66	3.87
Price/Cash Flow	- -	- -	- -	- -	-112.54	-46.36	-8.86	-9.51	-15.42	-68.31
Price/Cash Flow Average	- -	- -	- -	- -	-115.08	-61.07	-17.63	-10.22	-12.94	-38.93
Price/Cash Flow High	- -	- -	- -	- -	-129.23	-91.31	-33.16	-13.68	-19.49	-75.51
Price/Cash Flow Low	- -	- -	- -	- -	-103.96	-42.5	-8.32	-7.18	-8.19	-20.58
Price/Free Cash Flow Average	- -	- -	- -	- -	-75.7	-44.94	-14.1	-9.61	-11.29	-30.86
Price/Free Cash Flow High	- -	- -	- -	- -	-85.01	-67.19	-26.52	-12.87	-17	-59.86
Price/Free Cash Flow Low	- -	- -	- -	- -	-68.39	-31.27	-6.65	-6.76	-7.14	-16.31
EV/Sales Average	- -	- -	- -	- -	39.79	35.49	12.99	6.72	4.91	8.15
EV/Sales High	- -	- -	- -	- -	45.06	52.49	23.72	8.89	7.06	15.32
EV/Sales Low	- -	- -	- -	- -	35.65	25.06	6.55	4.82	3.36	4.55
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	- -	- -	119.96	95.64	26.82	27.6	30.14	100.67
High Price	- -	- -	- -	- -	137.74	188.38	100.43	39.69	38.08	111.28
Enterprise Value Average	- -	- -	- -	- -	11,409	13,262	5,838	3,791	3,631	8,004
Enterprise Value High	- -	- -	- -	- -	12,920	19,612	10,664	5,013	5,218	15,046
Enterprise Value Low	- -	- -	- -	- -	10,221	9,364	2,943	2,721	2,481	4,470

Shares Outstanding	84	84	86	94	100	102	103	122	124	131
Diluted Weighted Avg Shares	71	71	30	91	98	101	102	112	123	125
Basic Weighted Avg Shares	71	71	30	91	98	101	102	112	123	125
Revenue per Share	0.36	0.7	2.98	2.37	2.94	3.69	4.4	5.04	6.02	7.83
EBITDA per Share	-0.57	-1.01	-2.82	-0.78	-2.45	-3.84	-4.98	-4.66	-3.27	-3.17
Operating Income per Share	-0.62	-1.08	-3.06	-0.91	-2.61	-4.06	-5.33	-5.04	-3.61	-3.49
Basic EPS, GAAP	-0.65	-1.26	-2.8	-0.84	-2.6	-4	-6.41	-4.28	-3.56	-3.32
Basic EPS from Cont Ops	-0.65	-1.18	-2.77	-0.75	-2.53	-3.8	-6.41	-4.28	-3.56	-3.32
Diluted EPS, GAAP	-0.65	-1.26	-2.8	-0.84	-2.6	-4	-6.41	-4.28	-3.56	-3.32
Diluted EPS from Cont Ops	-0.65	-1.18	-2.77	-0.75	-2.53	-3.8	-6.41	-4.28	-3.56	-3.32
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.52	-1.02	-2.37	-0.52	-1.07	-2.06	-3.03	-2.9	-1.95	-1.47
Free Cash Flow per Basic Share	-0.54	-1.15	-3.04	-0.76	-1.62	-2.8	-3.79	-3.08	-2.24	-1.86
Cash & Equivalents per Share	1.14	2.65	4.88	5.55	17.91	9.17	9.85	9.61	6.77	9.2
Book Value per Share	-1.2	-2.29	5.63	8.47	12.96	6.34	0.59	1.3	-1.13	-0.76
Tangible Book Value per Share	-1.2	-2.39	5.54	8.27	12.76	6.17	0.44	1.2	-1.21	-1.55

Guardant Health, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)